| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be41078385205036f284d26d8a1a2c87 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-145 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-145 |
| filingDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7c810be2836dac8a23d2d15a75b6080
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c636513a075aed5bd7f2ee26196bd91d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf99ce41df267755b77e93972fbda9f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_263211f771597ec3d4bc8e6eeb13d98e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0d9f02741ee333d0449a81cce5c38b0 |
| publicationDate |
2020-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10576099-B2 |
| titleOfInvention |
Injectable scaffold for treatment of intracranial aneurysms and related technology |
| abstract |
A method for treating an aneurysm in accordance with a particular embodiment of the present technology includes intravascularly delivering a mixture including a biopolymer (e.g., chitosan) and a chemical crosslinking agent (e.g., genipin) to an aneurysm. The method further includes mixing the biopolymer and the chemical crosslinking agent to initiate chemical crosslinking of the biopolymer. The mixture is delivered to the aneurysm via a lumen and an exit port of a catheter while the chemical crosslinking is ongoing. The mixture exits the catheter as a single cohesive strand that at least partially agglomerates to form a mass occupying at least 75% of a total internal volume of the aneurysm. During delivery of the mixture, the method includes expanding a tubular flow diverter to reinforce a neck of the aneurysm. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4129352-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022198208-A1 |
| priorityDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |